Hislop Matthew, Brideaux Adam, Dhupelia Sanjay
Brisbane Sports and Exercise Medicine Specialists, 87 Riding Road, Hawthorne, Brisbane, QLD, 4171, Australia.
Gold Coast University Hospital, Gold Coast, Australia.
Skeletal Radiol. 2017 Sep;46(9):1241-1248. doi: 10.1007/s00256-017-2686-6. Epub 2017 Jun 9.
To determine whether ultrasound-guided injection of botulinum toxin type A (BTX-A) is a viable alternative to surgical intervention for the treatment of functional popliteal artery entrapment syndrome (PAES).
Twenty-seven patients met diagnostic criteria confirming the presence of functional PAES and agreed to go ahead with ultrasound-guided BTX-A injection at the level of artery occlusion. Patients were assessed and treated at baseline and given the option for 'top-up' injections at 6 and 12 months. Patients provided subjective symptom reports at 6 and 12 months post intervention.
No patients reported being worse off after the intervention; 59% of patients were categorized as having a good response (i.e., initial improvement that was maintained at 12 months), 22% a mixed response (i.e., an initial improvement that subsequently reduced over 12 months) and 19% a poor response (i.e., no difference) to treatment.
Ultrasound-guided BTX-A injection represents a viable alternative to surgery in the treatment of functional PAES. Further study will help determine the optimum dose and frequency of injection to prevent recurrence of symptoms.
确定超声引导下注射A型肉毒杆菌毒素(BTX-A)是否是治疗功能性腘动脉压迫综合征(PAES)的手术干预的可行替代方案。
27例患者符合确诊功能性PAES的诊断标准,并同意在动脉闭塞水平进行超声引导下的BTX-A注射。在基线时对患者进行评估和治疗,并在6个月和12个月时给予“补充”注射的选择。患者在干预后6个月和12个月提供主观症状报告。
没有患者报告干预后情况变差;59%的患者被归类为有良好反应(即最初改善并在12个月时维持),22%为混合反应(即最初改善随后在12个月内降低),19%对治疗反应不佳(即无差异)。
超声引导下BTX-A注射是治疗功能性PAES的手术的可行替代方案。进一步研究将有助于确定预防症状复发的最佳注射剂量和频率。